Modeling epigenetic lesions that cause gliomas.
Gilbert J Rahme1, Nauman M Javed1, Kaitlyn L Puorro2
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Disrupting a CTCF insulator near PDGFRA in mouse cells increases proliferation. Combined with Cdkn2a tumor suppressor loss, this drives glioma formation, offering insights into cancer drivers.
Area of Science:
- Cancer biology
- Epigenetics
- Genomics
Background:
- Epigenetic alterations disrupting regulatory elements are potential cancer drivers.
- Experimental models are needed to validate the tumorigenic impact of these lesions.
- Isocitrate dehydrogenase-mutant gliomas show DNA hypermethylation, suggesting epigenetic drivers.
Purpose of the Study:
- To model epigenetic aberrations in isocitrate dehydrogenase-mutant gliomas.
- To investigate the role of a CTCF insulator disruption near PDGFRA in gliomagenesis.
- To understand the cooperation between insulator disruption and tumor suppressor gene silencing.
Main Methods:
- Modeling of CTCF insulator disruption in mouse oligodendrocyte progenitor cells (OPCs).
- Analysis of PDGFRA oncogene activation by an OPC-specific enhancer.
- Assessment of Cdkn2a tumor suppressor silencing and its cooperation with insulator loss.
- In vivo gliomagenesis studies.
Main Results:
- Disruption of the CTCF insulator in mouse OPCs led to PDGFRA activation and increased proliferation.
- Methylation-dependent silencing of Cdkn2a cooperated with insulator loss.
- Coordinate inactivation of the PDGFRA insulator and Cdkn2a drove gliomagenesis in vivo.
- Human-specific CpG richness in the insulator complicates mouse modeling but suggests a role in human glioma risk.
Conclusions:
- Recurrent epigenetic lesions can drive oligodendrocyte progenitor cell proliferation in vitro.
- Coordinated epigenetic alterations, including insulator disruption and tumor suppressor silencing, drive gliomagenesis in vivo.
- The study highlights the potential of epigenetic lesions as cancer drivers and the challenges in modeling human-specific epigenetic features.
More Related Videos
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
04:01Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
